Health technology company, InteliCare (ASX:ICR):
announces important changes to its Board as part of the recent strategic restructuring of the business.
Including:
- ICR Founder and [Chair] Greg Leach to transition to Non-Executive Director
- Appointment of […] Dr Neale Fong as new Independent Non-Executive [Chair]
- Appointment of […] Cam Ansell as Independent None-Executive Director
- Appointment of an ICR Advisory committee
What is the new board getting paid?
[Chair] Fee - $90,000 per annum Non-Executive Director Fee — $45,000 per annum
See also: InteliCare (ASX:ICR) appoints new CEO from 9 days ago.